Latest Mass Tort News and Updates

Just when Xarelto plaintiff attorneys were rejoicing and preparing on the lines of the first Philadelphia Xarelto trial which brought in the first-ever win for the…

Invokana, (a diabetic medication and  SGLT2 inhibitor) was also in the news as the FDA now requires a serious boxed warning to be highlighted in the labels about the increased risk of leg and foot amputations. This…

Despite winning its first trial in November 2017, Testim gel makers, Auxilium, settled a lawsuit for an undisclosed amount, just days before the trial in Pennsylvania’s Philadelphia Court of Common Pleas. Allegations put forth by the…

Portola Pharmaceuticals received news of a second-time delay from the U.S. Food & Drug Administration (FDA) regarding the approval of AndexXa, an antidote developed to monitor uncontrollable bleeding linked to Xarelto and Eliquis.…

The FDA has shown no signs or indications regarding any ban on transvaginal mesh devices used to treat pelvic organ prolapse (POP) and stress urinary…

Eli Lilly and Company, the maker of Axiron used in the treatment of low testosterone levels is one of the defendants in the over 6,000 centralized …

Bayer received good news beginning of the year as the Missouri Supreme Court ruled in its favor regarding an Essure Lawsuit filed by 92 women for injuries allegedly caused…

The rising number of recalls, over the past years, on pharmaceutical products containing the cancer-causing chemical N-nitrosodimethylamine (NDMA) has made the drug industry to look for ways to prevent contamination.

Popular medication…

On Friday, Thomas Weaver, the attorney representing Johnson & Johnson (J&J) argued over a bid to reverse a jury’s $4.7 billion talcum powder verdict stating that the judge…

The first AndroGel bellwether trial announced in favor of the plaintiff awarding him $150 million as punitive damages and no compensatory damages in June 2017 was tossed by the U.S. District Judge Matthew F. Kennelly, overseeing 6,000 plus…